Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 until, on a Research Program-by-Research Program basis, the expiration of the applicable Research Term.
Appears in 2 contracts
Samples: Antibody Discovery and Option Agreement (Spyre Therapeutics, Inc.), Antibody Discovery and Option Agreement (ARCA Biopharma, Inc.)
Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 until, on a Research Program-by-Research Program basis, the earlier of (a) expiration of the applicable Research TermTerm and (b) Spyre’s exercise of the Option in accordance with Section 4.3.
Appears in 2 contracts
Samples: Antibody Discovery and Option Agreement (Spyre Therapeutics, Inc.), Antibody Discovery and Option Agreement (Aeglea BioTherapeutics, Inc.)
Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 until, on a Research Program-by-Research Program basis, the earlier of (a) expiration of the applicable Research TermTerm and (b) Apogee’s exercise of the Option in accordance with Section 4.3.
Appears in 1 contract
Samples: Antibody Discovery and Option Agreement (Apogee Therapeutics, Inc.)
Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 3.1 until, on a Research Program-by-Research Program basis, the earlier of (a) expiration of the applicable Research TermTerm and (b) Spyre’s exercise of the Option in accordance with Section 4.3.
Appears in 1 contract
Samples: Antibody Discovery and Option Agreement (Aeglea BioTherapeutics, Inc.)
Disbandment. The JDC shall remain in effect from the date on which it is established in accordance with Section 3.1 3.1 until, on a Research Program-by-Research Program basis, the expiration of the applicable Research Term.
Appears in 1 contract
Samples: Antibody Discovery and Option Agreement (ARCA Biopharma, Inc.)
